arrow
D

David C. Currow

Flinders University
H指数:86
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors associated with bowel cancer screening participation among First Nations Peoples receiving home health care services in New South Wales, Australia

影响澳大利亚新南威尔士州接受居家卫生保健服务的原住民参与结直肠癌筛查的因素

2026-08-070
OAAI
If You Want to Go Far, Go Together: Lessons Learned from Quality Improvement Collaboratives in Palliative Care

如果您想走得更远,就一起行动:从姑息治疗质量改进协作中汲取的经验教训

2026-08-010
PRE
Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluation

比较低剂量口服缓释吗啡在慢性呼吸困难患者中的疗效、成本效益及实施情况:一项随机对照试验和过程评估的概要

2026-05-010
PRE
Feasibility and acceptability of “LiCPain” pilot randomised controlled trial of continuous subcutaneous infusion of lidocaine or placebo for people with neuropathic cancer pain: a qualitative study of patient and carer perceptions and experiences

“LiCPain”试验的可行性及可接受性:一项关于对神经病理性癌痛患者连续皮下输注利多卡因或安慰剂的试点随机对照试验,以及患者和照护者对其感知与体验的定性研究

2026-03-170
OAAI
Non-Pharmacological Breathlessness Action Plans for People with COPD and Their Support People: A Scoping Review and Survey of Current Practice

非药物治疗性呼吸困难行动计划在COPD患者及其支持者中的应用:一项范围综述和当前实践调查

2026-01-010
OAAI
Implementing breathlessness self-management in low- and middle-income countries: co-design of breathlessness self-management resources for use in India

在低收入和中等收入国家实施呼吸困难自我管理:为在印度使用而共同设计呼吸困难自我管理资源

2025-11-240
OAAI
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国的吗啡治疗慢性呼吸困难 (MABEL): 对多站点,平行组,剂量滴定,双盲,随机,安慰剂对照试验的健康经济学评估

2025-11-050
OA
Toward a comprehensive research agenda: exploring the health economics of palliative care in Australia

迈向全面的研究议程:探索澳大利亚姑息治疗的健康经济学

2025-11-010
OAAI